NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 365 filers reported holding NEKTAR THERAPEUTICS in Q1 2018. The put-call ratio across all filers is 0.43 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $579,000 | -85.5% | 33,724 | -71.5% | 0.00% | -85.7% |
| Q1 2019 | $3,980,000 | +13.5% | 118,464 | +11.1% | 0.01% | -58.8% |
| Q4 2018 | $3,506,000 | -91.3% | 106,652 | -71.8% | 0.03% | -83.1% |
| Q1 2018 | $40,135,000 | +727.9% | 377,708 | +365.3% | 0.20% | +644.4% |
| Q4 2017 | $4,848,000 | +14.0% | 81,180 | -61.8% | 0.03% | -12.9% |
| Q2 2017 | $4,251,000 | -82.0% | 212,551 | -79.3% | 0.03% | -83.3% |
| Q1 2017 | $23,580,000 | – | 1,025,218 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 432,952 | $1,385,000 | 0.91% |
| GREAT POINT PARTNERS LLC | 447,820 | $1,433,000 | 0.34% |
| Birchview Capital, LP | 128,000 | $410,000 | 0.29% |
| Edgestream Partners, L.P. | 1,047,636 | $3,352,000 | 0.26% |
| Rhenman & Partners Asset Management AB | 550,000 | $2,068,000 | 0.22% |
| CM Management, LLC | 50,000 | $160,000 | 0.18% |
| TANG CAPITAL MANAGEMENT LLC | 430,037 | $1,376,000 | 0.17% |
| PDT Partners, LLC | 307,953 | $985,000 | 0.15% |
| Virtus ETF Advisers LLC | 72,018 | $230,000 | 0.09% |
| ALGERT GLOBAL LLC | 476,412 | $1,525,000 | 0.09% |